Home-Based System Relieves Cirrhosis Refractory Ascites
|
By HospiMedica International staff writers Posted on 11 Jan 2022 |
|
Image: An ascites patient with abdominal paracentesis scars (Photo courtesy of iStock)
A novel tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites, according to a new study.
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Patient Monitoring System
AlarmSense
Patient Preoperative Skin Preparation
BD ChloraPrep
Latest Patient Care News
- Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
- Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
- FDA-Cleared Finger Cuff Device Enables Home Blood Pressure Monitoring
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
Channels
Artificial Intelligence
view channel
AI Tool Uses Mammograms to Detect Common Cardiovascular Diseases
Cardiovascular disease, encompassing hypertension, ischemic heart disease, and stroke, is the leading cause of death in women. Many cases are detected late, as symptoms can be subtle and routine screening... Read more
AI Tool Predicts Post-Heart Attack Trajectories to Personalize Follow-Up
Acute myocardial infarction (heart attack) survivors often develop new comorbidities and complications that unfold over years. Predicting which patients will deteriorate and where problems will arise remains... Read more
Critical Care
view channel
Wearable Hormone Monitor Enables At-Home Detection of Primary Aldosteronism
Primary aldosteronism, a hormone disorder that affects up to one in five people with hypertension, increases risks of heart disease, stroke and diabetes. Many cases are missed because routine testing is... Read more
Contactless AI Tool Detects Hypertension and Diabetes from Facial Video
Hypertension and diabetes are widespread yet often undiagnosed, driving preventable cardiovascular morbidity and mortality. Screening typically depends on clinic visits or wearable devices, which can limit... Read more
Surgical Techniques
view channel
Biodegradable Gastric Stent Could Eliminate Repeat Procedures After Bariatric Surgery
Gastric leaks are a serious complication after weight-loss surgery that can lead to infection, prolonged hospitalization, and repeated interventions. Conventional drainage stents were designed for the... Read more
Robot-Assisted Surgery Shows Advantages Over Laparoscopy in Gastric Cancer
Gastric cancer is most often treated with surgery, yet minimally invasive techniques can be technically challenging. Laparoscopic gastrectomy reduces recovery time compared with open surgery but relies... Read more
Medical Imaging
view channel
Study Links Thymus Radiation Dose to Poorer Outcomes in Lung Cancer
Collateral radiation to the thymus during therapy for non-small cell lung cancer (NSCLC) may compromise antitumor immunity and disease control. The thymus is a small immune organ in the upper chest that... Read more
Automated AI Tool Enables Uncertainty-Aware Meningioma Volume Tracking on MRI
Magnetic resonance imaging (MRI) guides diagnosis and monitoring in brain tumors, yet routine measurements often rely on subjective reads or simplified two-dimensional calculations. These methods can miss... Read more
Health IT
view channel
Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
Calcinosis cutis involves calcium deposits in the skin or soft tissues that can develop anywhere in the body, causing pain, impaired mobility, and disability. Lesions along the spine or buttocks can make... Read more
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read more
Point of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. These limitations can slow diagnosis and restrict use... Read more
Business
view channel
Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
Cardiac arrhythmias affect millions of people worldwide and are often treated with catheter ablation. These procedures typically rely on X-ray fluoroscopy, which provides only indirect visualization of... Read more
Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
Atrial fibrillation increases stroke risk because blood clots often form in the left atrial appendage. For patients who cannot tolerate long-term anticoagulation, minimally invasive closure can provide... Read more
FDA Seeks Feedback on Regulating Generative AI Medical Devices
Generative artificial intelligence (AI) is rapidly entering clinical workflows, offering tools that could enhance patient care while introducing risks that differ from those of traditional software.... Read more